Telesis Bio Inc Revenu
Quel est le Revenu de Telesis Bio Inc?
Le Revenu de Telesis Bio Inc est $17.531M
Quelle est la définition de Revenu?
Le revenu est le revenu qu'une entreprise tire de ses activités commerciales normales, généralement de la vente de biens et de services aux clients.
Revenue is also referred to as sales or turnover. Some companies receive revenue from interest, royalties, or other fees. Revenue may refer to business income in general, or it may refer to the amount, in a monetary unit, earned during a period of time, as in "Last year, Company X had revenue of $42 million". Profits or net income generally imply total revenue minus total expenses in a given period.
In accounting, revenue is often referred to as the "top line" due to its position on the income statement at the very top. This is to be contrasted with the "bottom line" which denotes net income.
Revenu des entreprises dans Health Care secteur sur NASDAQ par rapport à Telesis Bio Inc
Que fait Telesis Bio Inc?
sgi-dna, a wholly owned subsidiary of synthetic genomics inc., provides genomic solutions to advance scientific discovery. sgi-dna’s ever expanding suite of products, services, reagents, bioinformatics tools and instrumentation enables scientists to discover, design and build novel solutions for basic research, as well as for biomedical and industrial applications. sgi-dna’s genomic services include whole genome sequencing, dna synthesis, library design, bioinformatics, cell engineering, and plasmid dna cloning and purification. sgi-dna’s reagents include a complete suite of gibson assembly® and site directed mutagenesis kits as well as optimized cell lines such as vmax™ a novel, fast growing host system for molecular biology. to further enable synthetic biology workflows, sgi-dna offers the bioxp™ 3200 system. this fully automated genomics workstation allows the creation of double stranded dna fragments, automated cloning, as well as next generation sequencing dna library preparation.
Entreprises avec revenu similaire à Telesis Bio Inc
- Kiadis Pharma N.V a Revenu de €17.500M
- Kiadis Pharma NV a Revenu de €17.500M
- Timeless Software a Revenu de HKD$17.506M
- Patagonia Gold a Revenu de $17.516M
- Henderson High Income Trust a Revenu de £17.520M
- i2S SA a Revenu de €17.520M
- Telesis Bio Inc a Revenu de $17.531M
- Sofibus Patrimoine S.A a Revenu de €17.539M
- BNK Banking a Revenu de AUD$17.560M
- Datasea a Revenu de $17.574M
- Datasea a Revenu de $17.574M
- Datasea a Revenu de $17.574M
- Datasea a Revenu de $17.574M